期刊文献+

Progress and challenges in the comprehensive management of chronic viral hepatitis: Key ways to achieve the elimination 被引量:2

下载PDF
导出
摘要 Chronic viral hepatitis is a significant health problem throughout the world,which already represents high annual mortality.By 2040,chronic viral hepatitis due to virus B and virus C and their complications cirrhosis and hepatocellular carcinoma will be more deadly than malaria,vitellogenesis-inhibiting hormone,and tuberculosis altogether.In this review,we analyze the global impact of chronic viral hepatitis with a focus on the most vulnerable groups,the goals set by the World Health Organization for the year 2030,and the key points to achieve them,such as timely access to antiviral treatment of direct-acting antiviral,which represents the key to achieving hepatitis C virus elimination.Likewise,we review the strategies to prevent transmission and achieve control of hepatitis B virus.Finally,we address the impact that the coronavirus disease 2019 pandemic has had on implementing elimination strategies and the advantages of implementing telemedicine programs.
出处 《World Journal of Gastroenterology》 SCIE CAS 2021年第26期4004-4017,共14页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献2

二级参考文献12

  • 1Konstantinos Tziomalos.Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B[J].World Journal of Hepatology,2010,2(3):91-93. 被引量:8
  • 2G. A. Niro,A. M. Ippolito,R. Fontana,M. R. Valvano,D. Gioffreda,A. Iacobellis,A. Merla,M. Durazzo,G. Lotti,L. Di Mauro,A. Andriulli.Long‐term outcome of hepatitis B virus‐related C hronic H epatitis under protracted nucleos(t)ide analogues[J].J Viral Hepat.2013(7)
  • 3Zhen Huan Cao,Li Na Ma,Hong Wei Zhang,Ya Li Liu,Xin Yue Chen.Extended treatment with peginterferon α‐2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion[J].Journal of Digestive Diseases.2013(8)
  • 4Roger Williams,Andrew P Holt.Screening immigrants for tuberculosis—why not for HBV infection?[J].The Lancet.2013(9884)
  • 5S. McPherson,M. Valappil,S. E. Moses,G. Eltringham,C. Miller,K. Baxter,A. Chan,K. Shafiq,A. Saeed,R. Qureshi,M. Hudson,M. F. Bassendine.Targeted case finding for hepatitis B using dry blood spot testing in the British–Chinese and South Asian populations of the North‐East of England[J].J Viral Hepat.2013(9)
  • 6A. K. Singal,H. Salameh,Y.‐F. Kuo,R. J. Fontana.Meta‐analysis: the impact of oral anti‐viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B[J].Aliment Pharmacol Ther.2013(2)
  • 7Ding-Shinn Chen,Stephen Locarnini,Suzanne Wait,Si-Hyun Bae,Pei-Jer Chen,James YY Fung,Hong Soo Kim,Sheng-Nan Lu,Joseph Sung,Junko Tanaka,Takaji Wakita,John Ward,Jack Wallace.Report from a Viral Hepatitis Policy Forum on Implementing the WHO Framework for Global Action on Viral Hepatitis in North Asia[J].Journal of Hepatology.2013
  • 8J. Kunkel,A. Ahmad,M. Levi,R. Reintjes,I. Veldhuijzen,G. Foster.972 SCREENING FOR VIRAL HEPATITIS AMONG MIGRANTS IN THE EU – THE QUEST FOR ‘GOOD SCREENING PRACTICE’[J].Journal of Hepatology.2013
  • 9Fasika B. Aberra,Mary Essenmacher,Natalie Fisher,Michael L. Volk.Quality Improvement Measures Lead to Higher Surveillance Rates for Hepatocellular Carcinoma in Patients with Cirrhosis[J].Digestive Diseases and Sciences.2013(4)
  • 10Monica Robotin,George,Patton.Getting it right: the impact of a continuing medical education program on hepatitis B knowledge of Australian primary care providers[J].International Journal of General Medicine (default).2013(default)

共引文献13

同被引文献13

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部